StemSynergy Therapeutics, Inc. Email Format
Biotechnology ResearchFlorida, United States2-10 Employees
StemSynergy Therapeutics, Inc. concentrates on identifying drug candidates that interfere with the core biomolecular pathways driving cancer. The company focuses on cancer stem/initiating cells, aiming to curb tumor growth. Based in Miami, Florida, the firm operates with a small team. The firm holds two granted patents and one pending patent for technologies that influence cancer stem cell pathways, including those governed by Wnt, Notch, and Sonic Hedgehog signaling. A 2021 press release notes that StemSynergy is advancing these molecules toward clinical development and holds worldwide exclusivity to bring them to the clinic.